Qube Research & Technologies (QRT)
AMGN icon

Qube Research & Technologies (QRT)’s Amgen AMGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.9M Buy
147,488
+139,570
+1,763% +$49.8M 0.06% 417
2025
Q4 		$2.59M Sell
7,918
-76,014
-91% -$24.1M ﹤0.01% 2138
2025
Q3 		$23.7M Sell
83,932
-173,682
-67% -$50.4M 0.02% 819
2025
Q2 		$71.9M Buy
257,614
+72,217
+39% +$20.5M 0.07% 349
2025
Q1 		$57.8M Sell
185,397
-1,092,029
-85% -$322M 0.07% 360
2024
Q4 		$333M Buy
1,277,426
+1,030,210
+417% +$306M 0.44% 23
2024
Q3 		$79.7M Sell
247,216
-813,835
-77% -$266M 0.12% 208
2024
Q2 		$332M Buy
1,061,051
+248,394
+31% +$73M 0.52% 19
2024
Q1 		$231M Buy
812,657
+778,584
+2,285% +$228M 0.37% 43
2023
Q4 		$9.81M Sell
34,073
-34,634
-50% -$9.44M 0.02% 742
2023
Q3 		$18.5M Sell
68,707
-474,024
-87% -$118M 0.05% 434
2023
Q2 		$120M Buy
542,731
+339,089
+167% +$78.7M 0.44% 48
2023
Q1 		$49.2M Sell
203,642
-304,998
-60% -$74.9M 0.21% 92
2022
Q4 		$134M Buy
508,640
+210,712
+71% +$56.5M 0.72% 7
2022
Q3 		$67.2M Sell
297,928
-284,994
-49% -$69.1M 0.4% 43
2022
Q2 		$142M Buy
582,922
+465,022
+394% +$114M 1.05% 6
2022
Q1 		$28.5M Buy
+117,900
New +$27.1M 0.24% 97
2021
Q4 		– Sell
-79,651
Closed -$16.9M – 2496
2021
Q3 		$16.9M Sell
79,651
-63,482
-44% -$14.6M 0.21% 104
2021
Q2 		$34.9M Buy
143,133
+122,607
+597% +$30.2M 0.4% 35
2021
Q1 		$5.11M Buy
+20,526
New +$4.9M 0.08% 323
2020
Q2 		– Sell
-13,574
Closed -$2.75M – 1691
2020
Q1 		$2.75M Buy
+13,574
New +$2.96M 0.11% 174
2019
Q4 		– Sell
-5,435
Closed -$1.05M – 1513
2019
Q3 		$1.05M Sell
5,435
-9,617
-64% -$1.85M 0.7% 27
2019
Q2 		$2.77M Buy
15,052
+225
+2% +$40.3K 0.66% 31
2019
Q1 		$2.82M Buy
+14,827
New +$2.83M 0.37% 61
2018
Q4 		– Sell
-19,160
Closed -$3.97M – 320
2018
Q3 		$3.97M Buy
19,160
+16,488
+617% +$3.25M 0.53% 42
2018
Q2 		$493K Buy
2,672
+1,327
+99% +$235K 0.31% 64
2018
Q1 		$229K Buy
+1,345
New +$247K 0.09% 144

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AMGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Amgen (AMGN) stake by 1,763% in Q1 2026, buying an estimated $49.8M and bringing the position to 147,488 shares worth $51.9M. The position accounts for 0.06% of the portfolio, ranked #417.

Qube Research & Technologies (QRT) first reported a position in AMGN in Q1 2018 and has held it in 27 quarters since. The position peaked at $333M in Q4 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 147,488 shares of Amgen worth $51.9M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 139,570 Amgen shares in Q1 2026, an estimated $49.8M.
  • Amgen made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #417 holding.
  • Qube Research & Technologies (QRT) first reported a position in Amgen in Q1 2018 and has held it in 27 quarters since.
  • Qube Research & Technologies (QRT)'s Amgen position peaked at $333M in Q4 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.